Carlsmed shareholders approve directors and auditor
Carlsmed, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026, where stockholders voted on director elections and auditor ratification.
Rhea-AI Filing Summary
Carlsmed, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026, where stockholders voted on director elections and auditor ratification. Niall Casey and Philip Young were elected as Class I directors to serve until the 2029 annual meeting or until successors are elected and qualified.
Casey received 19,627,716 votes for and 1,352,117 votes withheld, while Young received 19,510,686 votes for and 1,469,147 votes withheld, with 4,628,080 broker non-votes on each director proposal. Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 25,571,065 votes for, 5,858 against, and 30,990 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Niall Casey: 19,627,716 votes
Votes withheld for Niall Casey: 1,352,117 votes
Votes for Philip Young: 19,510,686 votes
+5 more
8 metrics
Votes for Niall Casey
19,627,716 votes
Election as Class I director at 2026 Annual Meeting
Votes withheld for Niall Casey
1,352,117 votes
Director election withholding tally
Votes for Philip Young
19,510,686 votes
Election as Class I director at 2026 Annual Meeting
Votes withheld for Philip Young
1,469,147 votes
Director election withholding tally
Broker non-votes on director elections
4,628,080 votes
Broker non-votes for each Class I director proposal
Votes for auditor ratification
25,571,065 votes
Ratifying Ernst & Young LLP for fiscal year ending December 31, 2026
Votes against auditor ratification
5,858 votes
Opposition to Ernst & Young LLP ratification
Abstentions on auditor ratification
30,990 votes
Abstaining votes on Ernst & Young LLP ratification
Key Terms
broker non-votes, independent registered public accounting firm, definitive proxy statement, Schedule 14A, +1 more
5 terms
broker non-votes financial
"Niall Casey ... 1,352,117 ... 4,628,080 broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
definitive proxy statement regulatory
"each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Schedule 14A regulatory
"described in more detail in the Company’s definitive proxy statement on Schedule 14A"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Carlsmed (CARL) stockholders vote on at the 2026 annual meeting?
Carlsmed stockholders voted on two proposals: electing two Class I directors and ratifying Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Both proposals received sufficient support to pass.
Which directors were elected at Carlsmed (CARL)’s 2026 Annual Meeting?
Stockholders elected Niall Casey and Philip Young as Class I directors. They will serve on the board of directors until the 2029 annual meeting of stockholders, or until their successors are duly elected and qualified, according to the meeting results.
How many votes did Carlsmed (CARL) director nominees receive in 2026?
Niall Casey received 19,627,716 votes for and 1,352,117 votes withheld. Philip Young received 19,510,686 votes for and 1,469,147 votes withheld. Each director proposal had 4,628,080 broker non-votes recorded in the final tally.
Was Ernst & Young LLP ratified as Carlsmed (CARL)’s auditor for 2026?
Yes. Stockholders ratified Ernst & Young LLP as Carlsmed’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 25,571,065 votes for, 5,858 votes against, and 30,990 abstentions recorded.
When was Carlsmed (CARL)’s 2026 Annual Meeting of Stockholders held?
Carlsmed held its 2026 Annual Meeting of Stockholders on June 3, 2026. At this meeting, stockholders considered and voted on the election of two Class I directors and the ratification of Ernst & Young LLP as the company’s independent auditor for 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
